about
Adeno-associated virus for cystic fibrosis gene therapyParticle transport and deposition: basic physics of particle kineticsTransduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.Vector serotype screening for use in ovine perinatal lung gene therapy.Current status of gene therapy for cystic fibrosis pulmonary disease.Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization propertiesHigh-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.Safety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia.Novel molecular approaches to cystic fibrosis gene therapy.DNA-based therapeutics and DNA delivery systems: a comprehensive review.The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS.Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.A truncated CFTR protein rescues endogenous DeltaF508-CFTR and corrects chloride transport in mice.Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma.Lentiviral vectors and cystic fibrosis gene therapyA Preclinical Study in Rhesus Macaques for Cystic Fibrosis to Assess Gene Transfer and Transduction by AAV1 and AAV5 with a Dual-Luciferase Reporter System.A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines.Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR.Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages.Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures.The CCT promoter directs high-level transgene expression in distal lung epithelial cell lines.Adeno-associated virus serotype 9-mediated pulmonary transgene expression: effect of mouse strain, animal gender and lung inflammation.Infant lungs are preferentially infected by adenovirus and herpes simplex virus type 1 vectors: role of the tissue mesenchymal cells.Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery.Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice.Dendrimers in RNAi Delivery
P2860
Q26823156-38A04C36-16FA-4504-9A79-275CBB60E828Q28391883-D69C2461-71FE-4888-AE9B-03762EE057A4Q33713277-4713D76C-B50E-496C-AA94-2715E149DD02Q33764220-DD348ED9-479E-4CAD-B832-A2F097F1DB26Q33975113-06007189-C097-40E1-A9E3-0FAF36368927Q34064665-F562285D-52DC-45FF-B5A4-17044B0F1D7AQ34228552-C2D6DBE9-84C8-4E42-BEC9-B42C8AB49D15Q34382965-2D82F462-4349-4642-991B-067FA85119EFQ34700126-EE7363C6-398D-44F4-B308-48DA516C808BQ35016463-4CC21039-717E-469A-8517-5FEA040780B9Q35150199-F57E9C34-AE83-4B68-AF7B-6CA39F7765ACQ36012920-F1DED90E-8FD7-44A5-B96A-795E3A800283Q36250777-59A4997F-B69F-4985-97D3-1C38C09AE5CFQ37141909-C20AE6EE-C332-434A-9C1E-F5DF1756344BQ37254889-F1E6A3FF-443C-4142-9DBB-3CD285046005Q37377588-C30EE87B-38D2-4392-A13A-4C76F73B65B1Q37415838-DD176BE6-0E05-4E30-98CB-5EB90F6203C5Q37664701-F6E4F482-8C0E-4C7E-8935-21E7C1E8AD27Q38614351-ACF8A940-5286-43E4-80AA-4D7271B15B11Q38670784-3297D09B-0CBC-4701-ADA6-42AEBE105A23Q39685433-5CC4F10E-AC96-4C27-8B19-246B1EC51842Q40387527-2768CAFD-473B-4F31-99D6-D0D80ED04CEEQ40615395-A3438893-9EB5-456F-B8F2-CEE4DBDAEE23Q41916695-75795CD6-1822-4F7A-8577-03713F114A54Q44493303-7B569FC0-973A-46E9-AAF3-7989E7134E26Q45367165-0E6E3D07-FD8C-435E-BB4D-662959FF4597Q45369052-5C9D17D7-AE53-42CB-B674-C3DE1250E954Q45886809-2604D233-ECDD-44CE-837B-CE90193C9CB2Q46632727-20C157DC-5FCF-4939-ABB6-E539F26B03CEQ57079937-D2E1D4EB-C6F1-4349-A3AC-F161A43D98C5
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gene therapy in cystic fibrosis.
@ast
Gene therapy in cystic fibrosis.
@en
Gene therapy in cystic fibrosis.
@nl
type
label
Gene therapy in cystic fibrosis.
@ast
Gene therapy in cystic fibrosis.
@en
Gene therapy in cystic fibrosis.
@nl
prefLabel
Gene therapy in cystic fibrosis.
@ast
Gene therapy in cystic fibrosis.
@en
Gene therapy in cystic fibrosis.
@nl
P1433
P1476
Gene therapy in cystic fibrosis.
@en
P2093
P304
P356
10.1378/CHEST.120.3_SUPPL.124S
P407
P433
P577
2001-09-01T00:00:00Z